Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Patrik Simmler
Observed name:
Simmler, Patrik
Observed institutions:
University of Zurich,
ETH Zurich,
Institute of Molecular Health Sciences
ORCID:
0000-0003-2883-275X
Observed ORCID:
0000-0003-2883-275X
OpenAlex ID:
A5039238875
Drug screening and genome editing in human pancreatic cancer organoids identifies drug-gene interactions and candidates for off-label therapy
2022
·
Christian K. Hirt
, Tijmen H. Booij
, et al.
·
Cell Genomics
·
94
PDF
Allele Loss and Reduced Expression of CYCLOPS Genes is a Characteristic Feature of Chromophobe Renal Cell Carcinoma
2019
·
Riuko Ohashi
, Peter Schraml
, et al.
·
Translational Oncology
·
20
PDF
SF3B1 facilitates HIF1-signaling and promotes malignancy in pancreatic cancer
2022
·
Patrik Simmler
, Cédric Cortijo
, et al.
·
Cell Reports
·
18
PDF
Mutant SF3B1 promotes malignancy in PDAC
2023
·
Patrik Simmler
, Eleonora I Ioannidi
, et al.
·
eLife
·
16
PDF
Role of disease duration, bio‐naivety, MoA and BMI in predicting PASI 100 under biologic therapy
2026
·
Rahel Looser
, Tatjana Marie Steybe
, et al.
·
Journal of the European Academy of Dermatology and Venereology
Author response: Mutant SF3B1 promotes malignancy in PDAC
2023
·
Patrik Simmler
, Eleonora I Ioannidi
, et al.
·
eLife
Show more works
View as search
Works count:
8
Citation count:
148
H-index:
4
I10-index:
4
Year
Topic
Type
